Source: DGNews  |  Posted 8 years ago

By Jane Salodof MacNeil

BOSTON, MA -- October 30, 2003 -- Human albumin produced better outcomes than polygeline and proved more cost effective in the first randomised, double-blind trial comparing colloids for intravascular fluid loading in patients with cirrhosis and ascites.

These results were presented here October 26th at the 54th Annual Meeting of the American Association for the Study of Liver Diseases.

The French government stopped the trial prematurely because of fears about Mad Cow disease -- synthetic polygeline is derived from bovine bone -- but the results were clearly in favor of albumin, according to researcher Richard Moreau, MD, H